Greenlight Biosciences Holdings PBC Stock Forecast, Predictions & Price Target

Analyst price target for GRNA

Based on 1 analyst offering 12 month price targets for Greenlight Biosciences Holdings PBC.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell GRNA stock?

Based on 1 analyst offering ratings for Greenlight Biosciences Holdings PBC.
Strong Buy
0 analysts 0%
0 analysts 0%
1 analysts 100%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GRNA stock forecasts and price targets.

GRNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Canaccord Genuity
Bottom 1%

1 of 1

GRNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
COYA$4.57$17.33+279.28%Strong Buy

Greenlight Biosciences Holdings Stock Forecast FAQ

Is Greenlight Biosciences Holdings Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GRNA) stock is to Hold GRNA stock.

Out of 1 analyst, 0 (0%) are recommending GRNA as a Strong Buy, 0 (0%) are recommending GRNA as a Buy, 1 (100%) are recommending GRNA as a Hold, 0 (0%) are recommending GRNA as a Sell, and 0 (0%) are recommending GRNA as a Strong Sell.

If you're new to stock investing, here's how to buy Greenlight Biosciences Holdings stock.

What is GRNA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GRNA price target, the average GRNA price target is $0.30, with the highest GRNA stock price forecast at $0.30 and the lowest GRNA stock price forecast at $0.30.

The Wall Street analyst predicted that Greenlight Biosciences Holdings's share price could reach $0.30 by May 31, 2024. The average Greenlight Biosciences Holdings stock price prediction forecasts a potential upside of 2.04% from the current GRNA share price of $0.29.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.